Evidence map›Paper›PMID 39587220›Full record

ArticleScientific reports2024

Development of flame retardant slow release insecticides paint and testing its efficacy for four years against dengue and malaria vectors.

Sunil Dhiman, Kavita Yadav, B N Acharya, Rajkumar Ahirwar, Ramarao Ghorpade, Sachin Tikar

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sunil DhimanVirology Division, Defence R&D Establishment, Gwalior, MP, 474002, India. sunildhiman81@gmail.com.
Kavita YadavVector Management Division, Defence R&D Establishment, Gwalior, MP, 474002, India.
B N AcharyaSynthetic Chemistry Division, Defence R&D Establishment, Gwalior, MP, 474002, India.
Rajkumar AhirwarSynthetic Chemistry Division, Defence R&D Establishment, Gwalior, MP, 474002, India.
Ramarao GhorpadeSynthetic Chemistry Division, Defence R&D Establishment, Gwalior, MP, 474002, India.
Sachin TikarVector Management Division, Defence R&D Establishment, Gwalior, MP, 474002, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insecticide based paint formulations have been available since years, however the concept of using such paint products at household level did not get attention due to various reasons. The advancement in insecticidal paint technology has steered toward the development and evaluation of such formulations for use against arthropod vectors. The improved insecticidal paint formulations may contain two or more active agents, hence could display different type of activity against the target vectors. In the present study, optimum concentrations of deltamethrin (1%), chlorpyriphos (0.5%) and pyriproxyfen (0.075%) were used as active ingredients (AIs) to develop flame retardant slow-release insecticides paint (FRSRIP) formulation. The developed formulation was tested for physico-chemical properties, toxicity and efficacy against two important mosquito vectors. The formulation was glossy, smooth, uniform and scratch proof. Furthermore, the formulation was flame retardant and conformed to class-A according to the guidelines. Acute oral, dermal and inhalation toxicity suggested that the formulation is safe for use in human dwellings. The formulation was evaluated against Ae. aegypti and An. stephensi mosquitoes in laboratory upto four years. It was found that KDT

Indexed as

DengueFlame RetardantsInsecticidesMalariaMosquito VectorsPaintAedesAnimalsAnophelesDelayed-Action PreparationsHumansMosquito ControlDelayed-Action PreparationsFlame RetardantsInsecticidesAedes aegyptiAnopheles stephensiChlorpyriphosDeltamethrinPyriproxyfenSlow-release

Identifiers

PMID39587220
PMCPMC11589166

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.